Found 18 matching trials
Humanized 3F8 Monoclonal Antibody (Hu3F8) When Combined With Interleukin-2 in Patients With High-Risk Neuroblastoma and GD2-positive Solid Tumors PHASE1 The purpose of this study is to find out if "humanized 3F8" (Hu3F8) when co...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia PHASE3 Drugs used in chemotherapy use different ways to stop cancer cells from div...
Show More Location
Cancer and Leukemia Group B
Learn More & Join Trial
HIV Reservoir Reduction With Interleukin-2 PHASE2 The purpose of this pilot study is to examine the effects of eight 4-day cy...
Show More Location
AIDS Clinical Trials Unit
Learn More & Join Trial
Cell Therapy of Cancer With Allogeneic Blood Lymphocytes Activated With Recombinant Interleukin-2 (rIL-2) for Metastatic Solid Tumors PHASE2 The present protocol is designed to investigate the potential application o...
Show More Location
Hadassah Medical Organization
Learn More & Join Trial
Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma PHASE1 RATIONALE: Vaccines made from a person's white blood cells combined with me...
Show More Location
Dana-Farber Cancer Institute
Learn More & Join Trial
Combination Chemotherapy With or Without Valspodar in Treating Patients With Previously Untreated Acute Myeloid Leukemia PHASE3 Randomized phase III trial to compare the effectiveness of combination chem...
Show More Location
Cancer and Leukemia Group B
Learn More & Join Trial
A Beta-only IL-2 ImmunoTherapY Study PHASE1 This is a Phase 1/2, multi-center, open-label, dose-escalation and expansio...
Show More Location
Sharp Memorial Hospital
Learn More & Join Trial
Combination Chemotherapy Plus PSC 833 Followed by Interleukin-2 in Treating Patients With Acute Myelogenous Leukemia PHASE1 RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Show More Location
University of California San Diego Cancer Center
Learn More & Join Trial
A Study to Evaluate the Effects of Giving Proleukin (rIL-2) to HIV-Positive Patients With CD4 Counts Greater Than 300 Cells/mm3 PHASE3 The purpose of this study is to examine how rIL-2 affects HIV-positive pati...
Show More Location
Community Consortium / UCSF
Learn More & Join Trial
An International Study to Evaluate Recombinant Interleukin-2 in HIV Positive Patients Taking Anti-retroviral Therapy PHASE3 The purpose of this study is to see if it is effective to give HIV positive...
Show More Location
VA Greater Los Angeles Healthcare System, Infectious Diseases Section CRS
Learn More & Join Trial